Anna Darby, MD, MPH in Los Angeles, CA - Medicare Provider

Anna Darby, MD, MPH is a medicare enrolled "Emergency Medicine" provider in Los Angeles, California. Her current practice location is 1200 N State St, Clinic Tower, Suite A7d, Los Angeles, California. You can reach out to her office (for appointments etc.) via phone at (510) 301-6293.

Anna Darby is licensed to practice in California (license number A153602) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1083077440.

Contact Information

	Anna Darby, MD, MPH
	1200 N State St, Clinic Tower, Suite A7d, Los Angeles, CA 90033-1029
	(510) 301-6293
	Not Available

Healthcare Provider's Profile

Full Name	Anna Darby
Gender	Female
Speciality
Experience	Years
Location	1200 N State St, Los Angeles, California
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Anna Darby attended and graduated from in

NPI Data:

NPI Number: 1083077440
Provider Enumeration Date: 04/03/2016
Last Update Date: 11/14/2022

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Anna Darby such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1083077440	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1835P0018X	Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist	A153602 (California)	Secondary
207P00000X	Emergency Medicine	A153602 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anna Darby is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Anna Darby, MD, MPH 1200 N State St, Clinic Tower, Suite A7d, Los Angeles, CA 90033-1029 Ph: () -	Anna Darby, MD, MPH 1200 N State St, Clinic Tower, Suite A7d, Los Angeles, CA 90033-1029 Ph: (510) 301-6293

News Archive

Deep-brain stimulation may stop uncontrollable shaking in patients with Parkinson's

Deep-brain stimulation (DBS) may stop uncontrollable shaking in patients with Parkinson's disease and essential tremor by imposing its own rhythm on the brain, according to two studies published recently by University of Alabama at Birmingham researchers in the journal Movement Disorders.

Opioid crisis strains foster care system; programs aim to keep kids with mom

After Raven Mosser gave birth six years ago, she woke up to a social worker in her hospital room. Her newborn son had been born exposed to opioids — drugs she had been abusing for years. If she didn't get clean, she was at risk of losing him.

Next generation sequencing applications automated through partnership between Beckman Coulter Life Sciences and New England Biolabs

Beckman Coulter Life Sciences, through a partnership with New England Biolabs®, Inc.

Researchers develop system that provides cognitive rehabilitation for patients with apraxia

Within the CogWatch European project, coordinated by the University of Birmingham, researchers at the Higher Technical School of Telecommunications Engineering and the Higher Technical School of Industrial Engineering of the Universidad Politécnica de Madrid have designed the architecture and the first prototype of a system that provides cognitive rehabilitation for patients suffering from apraxia.

Mix and match COVID-19 vaccines safe and effective: German study

A new preprint study posted to the medRxiv* server shows an AstraZeneca's ChAdOx1-nCov-19 and Pfizer/BioNTech BNT162b2 COVID-19 vaccine combination is immunologically superior to two AstraZeneca ChAdOx1-nCov-19 doses.

Anna Darby, MD, MPH - Medicare Pharmacist in Los Angeles, CA